Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06312124 · ClinicalTrials.gov registry record · NA

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

A NA study of Surgery, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
266
Enrollment target
10
Study locations

NCT06312124: Recruiting NA study of Surgery, sponsored by Memorial Sloan Kettering Cancer Center.

NCT06312124 is a NA study of Surgery that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 266 participants, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06312124, a NA study of Surgery, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
266 participants
Enrollment target
10
Study locations

Study Summary

The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

Primary Outcome

Evaluate the acceptance of Opportunistic Salpingectomy/OS among nongynecologic surgical patients after completion of an educational module

Conditions Studied

Surgery

Interventions

  • BEHAVIORAL Educational Module
  • PROCEDURE Salpingectomy

Study Locations (10)

New York

  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) - Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) - Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale

Maryland

  • Johns Hopkins University (Data Collection Only) - Baltimore

Massachusetts

  • Dana Farber Cancer Institute (Data Collection Only) - Boston

Texas

  • MD Anderson Cancer Center (Data Collection Only) - Houston

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2024-03-08
Est. Completion 2028-03-08
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT06312124 shows while recruiting

NCT06312124 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Educational Module is the first listed.

NCT06312124 lists 10 locations in 5 states (New York, New Jersey, Maryland).

Frequently Asked Questions

What is clinical trial NCT06312124 about?

NCT06312124 is a clinical study titled "A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer". The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

What is the current status of trial NCT06312124?

This trial is currently recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2024-03-08. Estimated completion is 2028-03-08.

What conditions does trial NCT06312124 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT06312124?

The interventions under investigation include: Educational Module (BEHAVIORAL), Salpingectomy (PROCEDURE).

Who is sponsoring clinical trial NCT06312124?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06312124 being conducted?

This trial has 10 study locations across Maryland, Massachusetts, New Jersey, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06312124's enrollment target sits among peer trials

266 34th of 120 higher than 87 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05098652 · 266 participants · NA

    Coaching Dementia Caregivers to Master Care-Resistant Behavior

  • NCT06088277 · 266 participants · NA

    Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

  • NCT06261814 · 266 participants · Phase 2

    Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

  • NCT06560866 · 266 participants · NA

    Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06312124

Source: ClinicalTrials.gov NCT06312124, the US trial registry maintained by the National Library of Medicine. NCT06312124 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.